A detailed history of New Age Alpha Advisors, LLC transactions in Novavax Inc stock. As of the latest transaction made, New Age Alpha Advisors, LLC holds 4,318 shares of NVAX stock, worth $35,364. This represents 0.0% of its overall portfolio holdings.

Number of Shares
4,318
Holding current value
$35,364
% of portfolio
0.0%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 12, 2025

BUY
$7.22 - $14.68 $31,175 - $63,388
4,318 New
4,318 $34.7 Million

Others Institutions Holding NVAX

About NOVAVAX INC


  • Ticker NVAX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 78,215,104
  • Market Cap $641M
  • Description
  • Novavax, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company's vaccine candidates include NVX-CoV2373, a coronavirus vaccine candidate that is in two Phase III trials, one Phase IIb trial, and one Phase I/II trial; Nan...
More about NVAX
Track This Portfolio

Track New Age Alpha Advisors, LLC Portfolio

Follow New Age Alpha Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of New Age Alpha Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on New Age Alpha Advisors, LLC with notifications on news.